Which chromosomal abnormality is most commonly associated with osteosarcoma?

Explanation

## Genetic Basis of Osteosarcoma **Key Point:** **TP53 mutations** (loss of p53 tumor suppressor function) are the most common genetic abnormality in osteosarcoma, present in approximately 50–70% of sporadic cases. ### p53 and Osteosarcoma Pathogenesis The p53 gene encodes a critical tumor suppressor protein that: - Regulates cell cycle checkpoints (G1/S and G2/M) - Triggers apoptosis in response to DNA damage - Maintains genomic stability Loss of p53 function removes a key brake on malignant transformation, allowing cells with DNA damage to proliferate unchecked. ### Li-Fraumeni Syndrome Connection **High-Yield:** Patients with **Li-Fraumeni syndrome** (germline TP53 mutations) have a dramatically elevated lifetime risk of osteosarcoma (~300-fold higher than the general population). This is one of the strongest genetic predispositions to osteosarcoma. ### Genetic Abnormalities in Osteosarcoma | Abnormality | Frequency | Significance | | --- | --- | --- | | TP53 mutation | 50–70% | Most common; associated with Li-Fraumeni syndrome | | RB gene loss | 30–40% | Retinoblastoma gene; often co-occurs with TP53 loss | | Amplification of 12q13–14 | ~30% | Includes MDM2 and CDK4 genes | | Complex karyotype | Most cases | Highly aneuploid; multiple chromosomal abnormalities | **Clinical Pearl:** The combination of **TP53 and RB pathway inactivation** is particularly common in osteosarcoma, reflecting the "two-hit" hypothesis of tumor suppressor loss. **Mnemonic:** **"p53 is PRIME for osteosarcoma"** — p53 mutations are the Primary and most Important genetic abnormality in osteosarcoma. [cite:Robbins 10e Ch 24]